CEBIOTEX SL
A Healthtech startup included in the Barcelona & Catalonia Startup Hub
CEBIOTEX
Cebiotex is an innovative clinical stage biotechnology start-up with the current mission to provide solutions to patients with cancer, both adult and paediatric through its CEBIOTEX Technological Platform patented at international level. First drug, CEB-01, in Ph1/2, is the first pharmaceutical product for Soft Tissue Sarcomas (STS) local control after tumour removal that covers an unmet oncological need by helping surgeons to obtain optimal results in their surgical interventions.
Industries & Technologies
Financial data
Other information
Funding
0.6M € (November 2020)
Capital
Investors: Capital Cell
0.7M € (September 2018)
Minority stake unknown %
Investors: UNDISCLOSED PRIVATE INVESTORS
0.3M € (May 2016)
Minority stake 10.71%
Investors: CROWD-FUNDING INVESTORS
Source: Press releases newsletters & platforms company websites annual reports & accounts regulatory body sites & stock exchanges
@cebiotex
Other startups near startup CEBIOTEX
similar companies
Collaborators of Barcelona & Catalonia Startup Hub.
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.